Pay in 4 interest-free payments of $14.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
23(3):274-6
InChiKey: GEPYBHCJBORHCE-SFHVURJKSA-N
InChiKey: WAOBCCBUTHNTFO-UHFFFAOYSA-N
In one of the clinical trials
PF-04979064 - PI3K/mTOR Dual Inhibitor. CAS# 1220699-06-8 hylase 23(3):274-6PF 04979064, CAS No. 1220699 06 8, is a highly potent and orally bioavailable PI3K mTOR dual inhibitor developed through structure based drug design. It inhibited mTOR, PI3K, , and isoforms and AKT phosphorylation with IC50 as 2. 64 nM, 0. 395 nM, 0. 111 nM, 0. 122 nM and 28. 3 nM, respectively. PF 04979064 exhibited cellular potency with an IC50 of 9. 1 nM in a BT20 cell assay. PF 04979064 exhibited excellent in vitro potency, very good solubility,
US$ 160.50
US$ 114.00
US$ 107.00
US$ 154.00
US$ 161.00
US$ 167.20
US$ 106.50
US$ 199.00